Core Viewpoint - The stock of Fengbei Bio (603334) reached its daily limit on February 5, closing at 59.08 yuan, driven by its unique position in the sustainable aviation fuel (SAF) market and alignment with national green policies [1] Group 1: Company Overview - Fengbei Bio is one of the few companies qualified to supply industrial-grade SAF blended oil and has established partnerships with leading SAF manufacturers such as HXN Energy, Jiaao Environmental Protection, and Phillips66 [1] - The company’s main business aligns with national green environmental policies, focusing on the comprehensive utilization of waste oils, which is a key area supported by resource recycling initiatives [1] - As a newly listed company on the main board under the registration system as of November 5, 2025, and recognized as a national-level "specialized and innovative" small giant, Fengbei Bio is experiencing increased policy and market attention [1] Group 2: Market Performance - On February 5, the stock saw a net inflow of 60.18 million yuan from main funds, accounting for 12.87% of the total trading volume, while retail investors experienced a net outflow of 27.86 million yuan, representing 5.96% of the total [2] - The stock's price increased by 10% on February 5, following a 9.99% rise on February 4, indicating strong upward momentum in recent trading days [2] - The company has established a complete industrial chain from waste oils to biodiesel and bio-based materials, with a market share of 6.46% in fertilizer additives, showcasing significant downstream collaboration advantages with leading agricultural chemical companies [1]

据交易所数据显示， 丰倍生物连续两个交易日涨停，晋级2连板。该股今日于10：11封涨停，成交额 3.44亿元，换手率19.17%。金融界App AI线索挖掘：该股属于生物柴油概念，近期市场对相关题材的关 注度较高，推动其股价连续走强。风险提示：连板股波动剧烈，注意追高风险，理性投资！（注：以上 由AI基于交易所等公开数据生成，内容不构成投资建议。） ...

会议演讲/路演报名（审核制） 请添加下方微信 声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文由仅作新材料相关领域介绍，本文不构成任何投资 建议！转载请注明来源！ 近日， 丰倍生物 （ 603334）接受投资者调研时表示，其生产的 生物柴油 主要用于对外销售和进一步 复配成生物柴油配方产品 ，同时2024年起随着公司对上游原料端的持续布局， 加大了工业级混合油对 外销售规模 。 公司2025年1-6月公司 生物柴油 产量为 47,706.75吨， 工业级混合油 产量为142,814.10 吨 。 据悉， 丰倍生物成立于2014年，是一家废弃资源综合利用领域的高新技术企业，主要以废弃油脂生产 资源化产品 。基于长期的研发投入和产业实践，公司在废弃油脂资源综合利用的深度及广度上不断拓 展，形成了 "废弃油脂—生物燃料（生物柴油）—生物基材料" 的废弃资源再生产业链。此外，公司还 依托自身油脂综合利用核心技术和渠道优势为客户提供油脂化学品。 其废弃油脂 主要来源于粮油食品加工企业、油脂化工企业、餐厨处理企业 等。公司在全国范围内多点 布局知名粮油食品加工企业、油脂化工企业、餐厨处理企业、 区 ...

Group 1 - The core viewpoint of the news is that Fengbei Bio has shown a mixed performance in terms of financing activities and stockholder statistics, with a notable increase in revenue and profit year-on-year [1][2] Group 2 - On January 19, Fengbei Bio's stock price increased by 0.54%, with a trading volume of 213 million yuan. The financing buy-in amount for the day was 11.46 million yuan, while the financing repayment was 12.08 million yuan, resulting in a net financing buy of -0.62 million yuan [1] - As of January 19, the total balance of margin trading for Fengbei Bio was 83.27 million yuan, accounting for 5.15% of its circulating market value [1] - The company has not engaged in any short selling activities on January 19, with no shares sold or repaid [1] Group 3 - As of December 10, the number of shareholders for Fengbei Bio was 27,600, a decrease of 50.19% compared to the previous period, while the average circulating shares per person increased by 100.77% to 1,123 shares [2] - For the period from January to September 2025, Fengbei Bio achieved an operating income of 2.251 billion yuan, representing a year-on-year growth of 62.32%, and a net profit attributable to shareholders of 117 million yuan, which is a 35.32% increase year-on-year [2] Group 4 - Fengbei Bio, established on July 25, 2014, is located in Changzhou, Jiangsu Province, and primarily focuses on the comprehensive utilization of waste oil resources, with oil chemical products as a secondary business [1] - The main business revenue composition includes 91.18% from waste resource utilization, with 79.60% from bio-based materials, 11.58% from biofuels, and 8.66% from oil chemical products [1]

资金流向方面，今日该股主力资金净流入6979.02万元，其中，特大单净流入7350.38万元，大单资金净 流出371.36万元。近5日主力资金净流入8134.74万元。 丰倍生物(603334)今日涨停，全天换手率32.27%，成交额4.80亿元，振幅8.78%。龙虎榜数据显示，营 业部席位合计净买入7752.57万元。 上交所公开信息显示，当日该股因日换手率达32.27%上榜，营业部席位合计净买入7752.57万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交1.44亿元，其中，买入成交额为1.11亿 元，卖出成交额为3306.60万元，合计净买入7752.57万元。 具体来看，今日上榜营业部中，第一大买入营业部为国泰海通证券股份有限公司总部，买入金额为 3105.67万元，第一大卖出营业部为高盛(中国)证券有限责任公司上海浦东新区世纪大道证券营业部，卖 出金额为894.88万元。 2025年11月4日公司发布的三季报数据显示，前三季度公司共实现营业收入22.51亿元，同比增长 62.32%，实现净利润1.17亿元，同比增长35.32%。（数据宝） 丰倍生物1月9日交易公开信息 | 买/ | ...

Core Viewpoint - Fengbei Bio (603334) is engaged in selling industrial-grade mixed oil to SAF (Sustainable Aviation Fuel) companies, which is further processed by downstream customers into SAF [1] Group 1: Company Overview - The company’s business includes the sale of industrial-grade mixed oil derived from waste oils, which is standardized according to customer requirements [1] - The industrial-grade mixed oil can be utilized in the production of biodiesel and biojet fuel [1]

Group 1 - The core point of the article is that Fengbei Bio (603334) announced that it does not have any other guarantee situations and has not provided guarantees for its controlling shareholders and actual controllers or their related parties [1] - The company confirmed that there are no overdue guarantees [1]

证券代码：603334 证券简称：丰倍生物 公告编号：2025-008 苏州丰倍生物科技股份有限公司 关于为全资子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | 被担保人名称 | 本次担保金额 | | 实际为其提供的 | | 是否在前期预计 | 本次担保是否有 | | --- | --- | --- | --- | --- | --- | --- | | | | | 担保余额（不含本 次担保金额） | | 额度内 | 反担保 | | 欧蒙化学品（江苏） 有限公司 | 1,000.00 | 万元 | 0.00 | 万元 | 是 | 否 | | 常州市金坛区维格 生物科技有限公司 | 1,000.00 | 万元 | 7,200.00 | 万元 | 是 | 否 | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0.00 | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（万元） | 14,000.00 | | 对外担保总额占上市 ...

Core Viewpoint - Fengbei Bio has completed the registration capital, company type, and revised articles of association registration procedures, and has obtained a new business license from the Suzhou Data Bureau [2] Group 1 - The company has recently undergone changes in its registered capital and company type [2] - Fengbei Bio has successfully completed the registration of its revised articles of association [2] - The company has received a new business license from the Suzhou Data Bureau [2]

证券代码：603334 证券简称：丰倍生物 公告编号：2025-007 苏州丰倍生物科技股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 苏州丰倍生物科技股份有限公司（以下简称"公司"）于 2025 年 12 月 9 日 召开第二届董事会第七次会议，审议通过了《关于变更公司注册资本、公司类型 及修订<公司章程>并办理工商变更登记的议案》，前述变更事项已经 2023 年第 一次临时股东大会审议通过的《关于提请股东大会授权董事会全权办理公司首次 公开发行股票并上市有关事宜的议案》、2025 年第一次临时股东大会审议通过的 《关于提请延长股东大会授权董事会全权办理公司首次公开发行股票并上市有 关事宜的议案》对董事会进行授权。具体内容详见公司于 2025 年 12 月 10 日在 上海证券交易所网站（www.sse.com.cn）以及公司指定信息披露媒体披露的《关 于变更注册资本、公司类型及修订<公司章程>并办理工商变更登记的公告》（公 告编号：2025-002）。 近日公司完 ...